Severe community-acquired pneumonia

Current outcomes, epidemiology, etiology, and therapy

Marcos Restrepo, James H. Jorgensen, Eric M. Mortensen, Antonio R Anzueto

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Severe community-acquired pneumonia is a clinical diagnosis with a significant impact on healthcare management around the world, with the highest morbidity and mortality of all of the forms of community-acquired pneumonia. Patients with severe pneumonia usually require intensive care unit management, including vasopressors or mechanical ventilation. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with severe pneumonia. A number of recent studies and guidelines addressing these issues have been published, and they will be reviewed in this article.

Original languageEnglish (US)
Pages (from-to)703-709
Number of pages7
JournalCurrent Opinion in Infectious Diseases
Volume14
Issue number6
StatePublished - 2001

Fingerprint

Pneumonia
Epidemiology
Therapeutics
Artificial Respiration
Intensive Care Units
Guidelines
Morbidity
Delivery of Health Care
Mortality

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Severe community-acquired pneumonia : Current outcomes, epidemiology, etiology, and therapy. / Restrepo, Marcos; Jorgensen, James H.; Mortensen, Eric M.; Anzueto, Antonio R.

In: Current Opinion in Infectious Diseases, Vol. 14, No. 6, 2001, p. 703-709.

Research output: Contribution to journalArticle

@article{4d63103c11904decaf5a9f1dbc3cee04,
title = "Severe community-acquired pneumonia: Current outcomes, epidemiology, etiology, and therapy",
abstract = "Severe community-acquired pneumonia is a clinical diagnosis with a significant impact on healthcare management around the world, with the highest morbidity and mortality of all of the forms of community-acquired pneumonia. Patients with severe pneumonia usually require intensive care unit management, including vasopressors or mechanical ventilation. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with severe pneumonia. A number of recent studies and guidelines addressing these issues have been published, and they will be reviewed in this article.",
author = "Marcos Restrepo and Jorgensen, {James H.} and Mortensen, {Eric M.} and Anzueto, {Antonio R}",
year = "2001",
language = "English (US)",
volume = "14",
pages = "703--709",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Severe community-acquired pneumonia

T2 - Current outcomes, epidemiology, etiology, and therapy

AU - Restrepo, Marcos

AU - Jorgensen, James H.

AU - Mortensen, Eric M.

AU - Anzueto, Antonio R

PY - 2001

Y1 - 2001

N2 - Severe community-acquired pneumonia is a clinical diagnosis with a significant impact on healthcare management around the world, with the highest morbidity and mortality of all of the forms of community-acquired pneumonia. Patients with severe pneumonia usually require intensive care unit management, including vasopressors or mechanical ventilation. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with severe pneumonia. A number of recent studies and guidelines addressing these issues have been published, and they will be reviewed in this article.

AB - Severe community-acquired pneumonia is a clinical diagnosis with a significant impact on healthcare management around the world, with the highest morbidity and mortality of all of the forms of community-acquired pneumonia. Patients with severe pneumonia usually require intensive care unit management, including vasopressors or mechanical ventilation. Early clinical suspicion and prompt empiric antimicrobial therapies are mandatory in patients with severe pneumonia. A number of recent studies and guidelines addressing these issues have been published, and they will be reviewed in this article.

UR - http://www.scopus.com/inward/record.url?scp=0035207527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035207527&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 703

EP - 709

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 6

ER -